An oncogenic role of XIST has been coherently indicated for other tumors, such as laryngeal squamous cell carcinoma, esophageal cancer and osteosarcoma (Table 1), whereas contrasting results have been published for hepatocellular carcinoma (HCC), where a tumor suppressor role has mainly been attributed. Here, XIST is linked to hepatocellular carcinoma.